Literature DB >> 22671695

Synthesis of chiral helical 1,3-oxazines.

Harish R Talele1, Sibaprasad Sahoo, Ashutosh V Bedekar.   

Abstract

A series of novel 1,3-oxazines were prepared to construct a helical framework. The 1,3-oxazine attached to the phenanthrene unit showed a small bite angle θ (∼12°), while the units attached to [4]helicene showed a larger θ (∼35°) and exhibited helical isomers at ambient conditions. The diastereomers of the third type of helicene-like bis-oxazine attached to binaphthyl were easily separable and showed good thermal stability. All four diastereomers of bis-helicene were synthesized, and their absolute configuration was established.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22671695     DOI: 10.1021/ol301267r

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Enantiomerically Pure 5,13-Dicyano-9-oxa[7]helicene: Synthesis and Study.

Authors:  Riddhi Gupta; Trevor A Cabreros; Gilles Muller; Ashutosh V Bedekar
Journal:  European J Org Chem       Date:  2018-09-15

2.  Synthesis of 6,6'-binaphthopyran-2-one natural products: pigmentosin A, talaroderxines A and B.

Authors:  Charles I Grove; Michael J Di Maso; Firoz A Jaipuri; Michelle B Kim; Jared T Shaw
Journal:  Org Lett       Date:  2012-08-13       Impact factor: 6.005

3.  Synthesis of enantiomerically pure helicene like bis-oxazines from atropisomeric 7,7'-dihydroxy BINOL: Preliminary measurements of the circularly polarized luminescence.

Authors:  M Shyam Sundar; Harish R Talele; Hemant M Mande; Ashutosh V Bedekar; Roberto C Tovar; Gilles Muller
Journal:  Tetrahedron Lett       Date:  2014-03-01       Impact factor: 2.415

4.  Circularly Polarized Luminescence from Helically Chiral N,N,O,O-Boron-Chelated Dipyrromethenes.

Authors:  Rua B Alnoman; Sandra Rihn; Daniel C O'Connor; Fiona A Black; Bernard Costello; Paul G Waddell; William Clegg; Robert D Peacock; Wouter Herrebout; Julian G Knight; Michael J Hall
Journal:  Chemistry       Date:  2015-11-30       Impact factor: 5.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.